Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis

Introduction and Objectives: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at an increased cardiovascular risk. On the contrary, non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with coronary heart disease (CHD). However, it is not known...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, Álvaro Urzúa, Katherine Rojas, Jaime Poniachik
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-07-01
Serija:	Annals of Hepatology
Teme:	Metabolic dysfunction-associated fatty liver disease Liver fibrosis Coronary heart disease
Online dostop:	http://www.sciencedirect.com/science/article/pii/S1665268124003053
Oznake:	Označite Brez oznak, prvi označite!